Twenty years of human bocavirus research: from an unculturable virus of unclear pathogenicity to a culturable human pathogen and gene therapy vector candidate
Clinical Microbiology Reviews · 11.12.2025 · 38 (4)
DOI: 10.1128/cmr.00173-24 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Microbiology Reviews, erschienen am 11.12.2025. Verfasst von Oliver Schildgen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Kliniken der Stadt Köln gGmbH, Institut für Pathologie, Klinikum der Privaten Universität Witten/Herdecke, Cologne, Germany. Hauptthemen laut MEDLINE: Human bocavirus, Parvoviridae Infections, Respiratory Tract Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 349 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Beatrix-Lichtken-Stiftung, NHLBI NIH HHS, Life and Heatlh Medical Association.
Abstract (Originalsprache)
Twenty years after the first description of human bocavirus 1 (HBoV1) as a respiratory pathogen, significant progress has been made in both clinical and basic research; however, important clinical, diagnostic, and molecular challenges remain before bocavirus pathobiology is fully understood. The discovery of HBoV1 and its notorious prolonged shedding have challenged the new sensitive multiplex PCR panel-based diagnostic testing that replaced the old antigen assays, leading to erroneous classification of HBoV1 as an innocent bystander. Both sophisticated diagnostics and cytopathic effects in cell culture have now confirmed HBoV1 to be a common cause of upper and lower respiratory tract infections, mainly in children. While many questions have been answered, new questions have emerged as our understanding of parvoviruses has significantly expanded over the past two decades. In this review, key findings from 20 years of clinical, basic, and applied research on human bocaviruses are summarized and open questions highlighted to guide future investigations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Kliniken der Stadt Köln gGmbH, Institut für Pathologie, Klinikum der Privaten Universität Witten/Herdecke, Cologne, Germany.
- Department of Microbiology, Molecular Genetics and Immunology, University of Kansas Medical Center, Kansas City, Kansas, USA.
- Department of Biochemistry and Molecular Biology, College of Medicine, Center for Structural Biology, McKnight Brain Institute, University of Florida, Gainesville, Florida, USA.
- Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
- Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden.
- Department of Pediatrics and Adolescent Medicine, University of Turku and Turku University Hospital, Turku, Finland.
ORCID-Profile: Oliver Schildgen, Jianming Qiu
Förderung
- Beatrix-Lichtken-Stiftung
- NHLBI NIH HHS
- Life and Heatlh Medical Association
- Lörcher-Stiftung
- NIAID NIH HHS
- NIGMS NIH HHS
- National Institute of Allergy and Infectious Diseases
- Sigrid Juséliuksen Säätiö
Zitieren
APA
Schildgen, O., Qiu, J., Mietzsch, M., Allander, T., Jartti, T., Schildgen, V., Grimm, D., & Söderlund-Venermo, M. (2025). Twenty years of human bocavirus research: from an unculturable virus of unclear pathogenicity to a culturable human pathogen and gene therapy vector candidate. Clinical Microbiology Reviews, 38(4). https://doi.org/10.1128/cmr.00173-24
Vancouver
Schildgen O, Qiu J, Mietzsch M, Allander T, Jartti T, Schildgen V, et al. Twenty years of human bocavirus research: from an unculturable virus of unclear pathogenicity to a culturable human pathogen and gene therapy vector candidate. Clinical Microbiology Reviews. 2025;38(4). doi:10.1128/cmr.00173-24
BibTeX
@article{Schildgen2025,
author = {Schildgen, Oliver and Qiu, Jianming and Mietzsch, Mario and Allander, Tobias and Jartti, Tuomas and Schildgen, Verena and Grimm, Dirk and Söderlund-Venermo, Maria},
title = {Twenty years of human bocavirus research: from an unculturable virus of unclear pathogenicity to a culturable human pathogen and gene therapy vector candidate},
journal = {Clinical Microbiology Reviews},
year = {2025},
volume = {38},
number = {4},
doi = {10.1128/cmr.00173-24}
}
EUVIMED